SETMAR Antibody

What is SETMAR and why is it significant for epigenetic research?

SETMAR is a histone methyltransferase that methylates Lys-4 and Lys-36 of histone H3, creating specific tags for epigenetic transcriptional activation. It specifically mediates dimethylation of H3 Lys-36. What makes SETMAR unique is its structure - in anthropoid primates, it contains a SET methyltransferase domain fused to a DNA transposase domain derived from the Hsmar1 transposable element . This fusion protein plays roles in DNA repair, gene regulation, and chromosome decatenation. The significance of SETMAR extends beyond basic epigenetic mechanisms, as it is dysregulated in several cancers, including glioblastoma, leukemia, breast cancer, and mantle cell lymphoma .

What are the key domains and functional characteristics of SETMAR?

SETMAR contains two primary domains with distinct functions: the N-terminal SET domain with methyltransferase activity and the C-terminal transposase domain that provides DNA-binding specificity. The SET domain specifically methylates histone H3 at lysine positions 4 and 36, creating tags for transcriptional activation . The transposase domain confers sequence-specific DNA-binding capability toward the 19-mer core of the 5'-terminal inverted repeats (TIRs) of the Hsmar1 transposable element . Additionally, SETMAR exhibits DNA nicking activity and in vivo end-joining function, which enables it to potentially mediate genomic integration of foreign DNA . This combination of epigenetic and DNA-binding activities makes SETMAR a multifunctional protein at the intersection of chromatin regulation and DNA processing.

What species express SETMAR and how conserved is the protein?

The full-length SETMAR protein containing both the SET domain and DNA transposase domain is specific to anthropoid primates . While SETMAR gene orthologs have been reported in mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken species , the structures differ significantly. In mice, SETMAR contains only the SET domain . The protein shows wide expression patterns in human tissues, with highest expression in placenta and ovary and lowest expression in skeletal muscle . When selecting antibodies for cross-species applications, researchers should note that human SETMAR antibodies may cross-react with monkey, bovine, and sheep proteins, as indicated by predictive reactivity data .

How should researchers select an appropriate SETMAR antibody for specific applications?

Selecting the optimal SETMAR antibody requires methodical evaluation of several factors:

• Application compatibility: Different antibodies perform optimally in specific applications. For Western blot detection, antibodies like those from ThermoFisher and Aviva Systems show good results with 70-75kDa bands in human cell lysates . For immunofluorescence, antibodies from Santa Cruz and Leading Biology have validated reactivity .

• Target domain specificity: Determine whether your research requires detection of the full-length protein, the SET domain alone, or the transposase domain. SETMAR encodes eight different mRNA isoforms with various domain combinations .

• Species reactivity: Verify species-specific reactivity. For untested species, perform amino acid sequence alignments between the immunogen sequence and your target protein, with >80% alignment providing good indication of potential cross-reactivity .

• Clonality selection: Polyclonal antibodies offer broader epitope recognition, while monoclonal antibodies provide consistent lot-to-lot reproducibility. For SETMAR detection, polyclonal antibodies currently dominate the market .

• Validation data review: Examine antibody datasheets for validation in your specific application. For example, the Aviva Systems antibody (OAEB01407) demonstrates detection of a 70-75kDa band in Daudi lysate by Western blot .

What experimental controls are essential when working with SETMAR antibodies?

Rigorous experimental design with SETMAR antibodies requires:

• Positive controls: Use cell lines known to express SETMAR, such as Daudi cells which show detectable levels by Western blot . For recombinant protein controls, commercially available SETMAR proteins can serve as standards.

• Negative controls: Include samples with SETMAR knockdown or knockout. For tissue analysis, skeletal muscle samples can serve as low-expression controls .

• Loading controls: For Western blots, standard housekeeping proteins like β-actin or GAPDH are essential to normalize expression levels.

• Secondary antibody controls: Include samples without primary antibody to rule out non-specific binding of secondary antibodies.

• Cross-reactivity validation: If analyzing multiple species, include samples from each to verify specific detection patterns, especially when examining the eight different SETMAR isoforms present in human tissues .

• Citation verification: Check published research that used your antibody of interest through Research Resource Identifiers (RRIDs) to ensure reproducibility .

How can researchers investigate SETMAR's role in DNA damage repair pathways?

To systematically study SETMAR's functions in DNA repair:

• Modulate SETMAR expression through overexpression or knockdown systems. Compare wild-type SETMAR with methyltransferase-deficient mutants to dissect domain-specific functions .

• Induce DNA damage using ionizing radiation or DNA-damaging agents and quantify repair efficiency through comet assays or γH2AX foci resolution.

• Monitor SETMAR recruitment to damage sites via ChIP or immunofluorescence approaches. SETMAR recruitment is enhanced by phosphorylation at Ser-508 following DNA damage .

• Analyze interactions with known DNA repair factors. SETMAR interacts with PRPF19, DNA ligase IV, and XRCC4 during repair processes .

• Assess impact on NHEJ pathway by measuring repair efficiency using reporter assays. Compare results with methyltransferase-deficient SETMAR to determine how epigenetic modifications influence repair outcomes .

• Investigate the phosphorylation status of SETMAR at Ser-508 by CHEK1, which is enhanced by DNA damage and promotes recruitment to damaged DNA .

What approaches can effectively examine SETMAR's gene regulatory functions?

To investigate SETMAR's role in transcriptional regulation:

• Perform ChIP-exo experiments to precisely map SETMAR binding sites throughout the genome, particularly at Hsmar1 transposon remnants. Approximately 6334 ITRs in the human genome still retain at least 80% homology to the canonical 28 bp ITR sequence .

• Conduct RNA-seq following SETMAR modulation. Studies have shown that modest SETMAR overexpression changes the expression of almost 1500 genes by more than 2-fold, with 65% up-regulated and 35% down-regulated .

• Compare transcriptional effects between wild-type and methyltransferase-deficient SETMAR. Expression of methylase-deficient SETMAR changes many fewer genes, with 77% down-regulated, highlighting the importance of methyltransferase activity .

• Quantify histone modification levels (H3K36me2, H3K4me3) and RNA polymerase II recruitment at target genes using ChIP-qPCR. SETMAR binding correlates with increased H3K36me3 marks at target genes .

• Analyze enrichment of specific pathways affected by SETMAR regulation. SETMAR-regulated genes are significantly enriched for KEGG Pathways in Cancer and include several transcription factors important for development and differentiation .

How should researchers interpret SETMAR's role in cancer biology?

SETMAR's involvement in cancer pathways requires nuanced analysis:

• Compare SETMAR expression and splicing patterns across cancer types. SETMAR is dysregulated in glioblastoma, leukemia, hematologic neoplasms, breast cancer, colon cancer, and mantle cell lymphoma .

• Analyze the eight different SETMAR mRNA isoforms in cancer tissues. Splicing factors NONO and SFPQ regulate SETMAR alternative splicing in bladder cancer .

• Examine the correlation between SETMAR binding sites and cancer-associated genes. SETMAR-regulated genes are enriched for KEGG Pathways in Cancer .

• Investigate SETMAR's epigenetic modifications at promoters of oncogenes and tumor suppressors. SETMAR binding correlates with H3K36me2 marks, potentially affecting DNA methylation maintenance .

• Assess whether SETMAR's DNA repair functions contribute to therapy resistance. Its role in NHEJ and replication fork restart may influence cellular responses to DNA-damaging agents .

Why might Western blot detection of SETMAR show unexpected banding patterns?

Multiple factors can influence SETMAR detection patterns:

• Isoform complexity: The human SETMAR gene encodes eight different mRNA isoforms with variable combinations of domains. Only one isoform encodes the full-length protein with both SET and transposase domains, while others contain only the SET domain, only the transposase domain, or no complete domain .

• Post-translational modifications: SETMAR undergoes methylation at Lys-335 and Lys-498, which can affect protein mobility. Additionally, phosphorylation at Ser-508 by CHEK1 is enhanced by DNA damage .

• Antibody specificity: Some antibodies target specific regions of SETMAR. The Aviva Systems antibody (OAEB01407), for example, targets the peptide sequence RWQKCVDCNGSYFD , while the St John's Laboratory antibody targets amino acids 20-300 .

• Sample preparation effects: Use fresh samples with protease inhibitors since SETMAR may undergo degradation. Expected molecular weight for the canonical isoform is approximately 70-75 kDa .

• Cross-reactivity: Some antibodies might detect related SET domain-containing proteins. Validate specificity using SETMAR knockdown controls.

What are the challenges in optimizing ChIP experiments for SETMAR?

ChIP experiments with SETMAR present several technical challenges:

• DNA binding specificity: SETMAR binds sequence-specifically to Hsmar1 transposon remnants. Design primers targeting the approximately 6334 ITRs that still have at least 80% identity to the canonical 28 bp ITR sequence .

• Isoform-specific targeting: Different SETMAR isoforms may have distinct DNA binding properties. Consider using domain-specific antibodies to distinguish binding patterns .

• Indirect binding effects: SETMAR interacts with multiple protein partners including DNA repair factors and DNA replication factors (topoisomerase 2α, PCNA, and RAD9) . Use stringent washing conditions to distinguish direct from indirect binding.

• Crosslinking optimization: For histone modifications induced by SETMAR, dual crosslinking with both formaldehyde and protein-specific crosslinkers may improve detection.

• Sonication parameters: Optimize sonication conditions to ensure efficient shearing of chromatin around Hsmar1 elements, which might have distinct chromatin structures.

How can researchers investigate the evolutionary significance of SETMAR?

Understanding SETMAR's evolutionary history requires specialized approaches:

• Comparative genomic analysis: Compare SETMAR gene structures across different species. In mouse, SETMAR contains only the SET domain and homozygous deletion causes phenotypic defects in vision, behavior, metabolism, and immune function .

• Functional domain comparison: The DNA transposase domain of SETMAR appears specifically conserved in anthropoid primates, suggesting specialized functions. Examine sequence conservation patterns using Ka/Ks ratios to identify evolutionary pressures .

• Transposon element mapping: Analyze the distribution of approximately 7000 Hsmar1 remnants in the human genome. Almost half are Made1 elements, which are miniature-transposons comprised of 6 bp flanked by a pair of ITRs, with about 500 annotated as miRNAs or miRNA-like elements .

• Domain-specific antibody utilization: Use antibodies targeting either the SET domain or transposase domain to compare functions across species.

• Isoform expression profiling: Quantify the expression of the eight different SETMAR mRNA isoforms across tissues and species. The most expressed human isoform encodes a SETMAR protein containing only the DNA transposase domain .

What are the methodological approaches to study SETMAR's non-histone methylation targets?

To characterize SETMAR's activity beyond histone modifications:

• Methylation substrate screening: SETMAR methylates non-histone targets including the splicing factor snRNP70 at lysine 170 and SPTBN2 (a spectrin). Use proteomic approaches to identify additional targets .

• Auto-methylation analysis: SETMAR performs auto-methylation on lysines 335 and 498. Methylation of lysine 498 inhibits SETMAR activity in chromosome decatenation, while lysine 335 methylation might regulate protein-protein interactions .

• Functional assessment: For identified methylation targets, perform site-directed mutagenesis of methylated residues and assess functional consequences.

• Methylation-specific antibody development: Generate antibodies that specifically recognize methylated forms of key targets to track methylation dynamics.

• In vitro methylation assays: Use purified SETMAR and candidate substrates to validate direct methylation activity and identify specific residues targeted.